Felicitas-Klinikka

What Felicitas-Klinikka does

Felicitas Mehiläinen (operating brand of Felicitas-Klinikka) is a Finnish specialty fertility clinic founded in 1990 and operating today as part of the Mehiläinen healthcare group. It delivers comprehensive infertility diagnosis and treatment for individuals and couples across Finland, with core services spanning initial nurse and physician consultations, fertility investigations (hormonal testing, ultrasound, semen analysis, MiOXSYS oxidative stress testing, fallopian tube patency studies), and assisted reproductive technologies including IUI, IVF, and ICSI. Advanced laboratory capabilities include Embryoscope / time-lapse embryo culture, blastocyst culture, vitrification-based embryo and gamete freezing, preimplantation genetic testing (PGT-A, PGT-M, PGT-SR, niPGT-A), and modified sperm selection techniques (PICSI, LAISS). In 2024 the clinic became the first in Finland to adopt AI-based oocyte quality assessment using computer vision on egg images.

The clinic serves heterosexual couples facing involuntary infertility, single women and female couples using donor gametes, co-parenting families, and patients with elevated genetic, chromosomal, or endometriosis-related risk. Adjacent offerings include fertility preservation (egg and sperm freezing), pregnancy monitoring and maternity services, gamete donation programs, genetic counseling, and psychological/sexual therapy. Revenue is generated per treatment cycle and ancillary service within the Finnish private healthcare system, with Kela (social insurance) reimbursing part of consultation costs for eligible patients; a free initial 30-minute infertility nurse consultation functions as a lead-generation funnel.

Felicitas operates four main clinics (Helsinki, Turku, Oulu, Lappeenranta), a satellite clinic in Vaasa, and nationwide remote video/phone consultations. Service delivery, appointment booking, and patient records are integrated into the parent Mehiläinen digital infrastructure, including the OmaMehiläinen patient portal. The clinic reports cumulative clinical outcomes of 17,500 children born through its treatments and approximately 80% of treated patients achieving parenthood.

Name

Felicitas-Klinikka

Legal name

Felicitas Mehiläinen

Website

https://felicitas.mehilainen.fi

Company type

Private

Founded year

1990

Operating status

Operating

Short description

Felicitas Mehiläinen is a Finnish specialty fertility clinic (founded 1990) operating within the Mehiläinen healthcare group, providing IVF, ICSI, IUI, PGT, and fertility preservation across four clinics, one satellite, and remote consultations nationwide.

Ownership category

akta.pro rank

Product category

Fertility and Reproductive Healthcare Services

NAICS

Family Planning Centers (62141), Family Planning Centers (621410)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling) (HLALAHAK), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)

Keywords

• Fertility treatment services
• Infertility diagnostics
• Assisted reproduction
• In vitro fertilization
• Reproductive healthcare

Headquarters

HQ city

Helsinki

HQ country

Finland

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Fertility Treatment Services: Felicitas Mehiläinen generates revenue from providing fertility consultations, infertility investigations, and assisted reproduction treatments (IUI, IVF, ICSI). Revenue comes from individual treatment cycles, diagnostic procedures, and follow-up care. The clinic operates within the Finnish private healthcare system, with pricing available on their published fee schedule.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Felicitas Mehiläinen is a fertility clinic providing comprehensive infertility investigations and assisted reproduction treatments (IUI, IVF, ICSI) along with advanced laboratory services such as embryo freezing, blastocyst culture, Embryoscope time-lapse monitoring, preimplantation genetic testing (PGT-A/M/SR), and AI-based oocyte quality assessment. Supporting offerings include fertility health consultations, pregnancy monitoring, gamete donation programs, genetic counseling, and psychological therapy services for individuals and couples across Finland.

Product overview

Felicitas-Klinikka is a fertility clinic offering a comprehensive, unified service portfolio centered on infertility diagnosis and treatment. The core offering includes Lapsettomuustutkimukset (infertility investigations) for both women and men, followed by Lapsettomuushoidot (infertility treatments) spanning insemination (IUI), IVF, and ICSI. Advanced laboratory services include embryo freezing (vitrification), blastocyst culture, Embryoscope culture, and time-lapse microscopy for enhanced embryo monitoring. Genetic services include preimplantation genetic testing (PGT-A, PGT-M, PGT-SR). The clinic recently added AI-based oocyte quality assessment for improved treatment planning. Supporting services include fertility health consultations, pregnancy monitoring, gamete donation, genetic counseling, and therapy. The clinic operates in Helsinki, Turku, Oulu, and Lappeenranta with satellite services in Vaasa, plus remote consultations.

Differentiator

Problem solved

Functional benefit

Products and services

• Lapsettomuushoidot (Infertility treatments) Comprehensive infertility treatment services including insemination (IUI), IVF, ICSI, and related procedures for treating involuntary infertility in individuals and couples.
• Lapsettomuustutkimukset (Infertility investigations) Diagnostic services to determine causes of infertility for both women and men, including hormonal testing, ultrasound examinations, semen analysis, and specialized analyses such as MiOXSYS oxidative stress testing.
• Inseminaatio (IUI - Intrauterine insemination) Artificial insemination procedure where washed sperm is injected into the uterine cavity during ovulation, used for mild sperm disorders, unexplained infertility, and treatments using donor sperm.
• Koeputkihedelmöitys (IVF - In vitro fertilization) In vitro fertilization treatment where eggs are collected, fertilized in laboratory conditions, and embryos are cultured before transfer to the uterus. The most effective infertility treatment method offered.
• Mikrohedelmöitys (ICSI - Intracytoplasmic sperm injection) Microfertilization technique where a single sperm is injected directly into the egg using micormanipulation, primarily indicated for male factor infertility. Advanced variants LAISS and PICSI are used to select viable sperm.
• Alkioiden pakastus (Embryo freezing/vitrification) Embryo preservation using vitrification (rapid freezing) technique, allowing storage of surplus good-quality embryos for future use. Reported frozen embryo survival rate of approximately 98%.
• Blastokystiviljely (Blastocyst culture/prolonged embryo culture) Extended embryo culture to blastocyst stage (5-7 days) allowing better selection of viable embryos for transfer.
• Embryoskooppi (Embryoscope culture) Incubator with integrated camera system that continuously monitors embryo development without disturbing optimal culture conditions, improving embryo selection for transfer.
• Time lapse -mikroskooppi (Time-lapse microscopy) Camera system in incubator that captures images at regular intervals to create videos showing early embryo development stages, available at the Turku clinic.
• Alkiodiagnostiikka (PGT - Preimplantation genetic testing) Genetic testing of embryos including PGT-A (aneuploidy screening), PGT-M (monogenic diseases), PGT-SR (chromosomal rearrangements), and niPGT-A (non-invasive PGT from culture medium) performed during IVF treatment.
• Munasolujen laadun arviointi (AI-based oocyte quality assessment) AI-assisted method for evaluating oocyte quality using imaging and AI analysis, providing more accurate assessment for IVF treatment planning and prediction of treatment success.
• Hedelmällisyysterveys (Fertility health services) Fertility health consultation and preventive services including fertility checks, egg freezing, sperm freezing, and lifestyle guidance.
• Raskauden seuranta ja synnytys (Pregnancy monitoring and delivery) Comprehensive pregnancy monitoring services including NIPT screening, ultrasound examinations, maternity clinic services, childbirth fear support, and physiotherapy.
• Sukusolujen luovutus (Gamete donation) Sperm and egg donation services with carefully selected and registered donors, available for couples, single women, and female couples.
• Terapiapalvelut (Therapy services) Psychological support including individual therapy, couples therapy, and sexual therapy for patients undergoing fertility treatments.
• Perinnöllisyyden tutkiminen (Genetic counseling) Genetic counseling services including carrier screening and hereditary disease risk assessment, with consultation by a genetics specialist.
• Lapsettomuushoitajan maksuton vastaanotto (Free infertility nurse consultation) Free initial consultation with an infertility nurse to discuss fertility health, lifestyle factors, and treatment options. Conducted in-person or remotely.

Quantifiable outcome

• 17,500 children born through Felicitas Mehiläinen treatments
• +6 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature7 records

Partnerships

One partnership is on record.

• MehiläinencoreStrategic or Co-development PartnerFelicitas operates as part of the Mehiläinen healthcare group (Mehiläinen konserni), one of Finland's largest private healthcare providers. The Mehiläinen brand provides operational infrastructure, digital platforms (OmaMehiläinen patient portal), and cross-referral networks. Felicitas Mehiläinen benefits from the Mehiläinen group's scale, brand recognition, and digital ecosystem while maintaining its specialized fertility focus. The clinic's website, booking systems, and patient records are integrated into the Mehiläinen infrastructure.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Ovumia Helsinki: Direct Finnish competitor operating fertility clinics in Helsinki and Tampere, offering IVF, ICSI, IUI, and preimplantation diagnostics to a similar patient base of infertile couples and single women in Finland.
• Dextra Fertility Clinic: Long-established Finnish fertility clinic in Helsinki providing IVF, ICSI, fertility investigations, and donor gamete treatments—comparable service portfolio and patient demographics.
• AVA Clinic: Finnish fertility clinic providing assisted reproduction treatments, donor gamete services, and fertility investigations with overlapping service offering and target patient segments.
• Nordica Fertility Clinic: Danish fertility clinic offering IVF, ICSI, and donor treatments with comparable technology stack and target demographic—comparable Nordic fertility provider with similar regulatory and reimbursement environment.
• Copenhagen Fertility Center: Independent Danish fertility center offering IVF, ICSI, egg donation, and fertility preservation—directly comparable in service mix, Nordic regulatory context, and patient demographic.

Broad incumbents

• Mehiläinen Fertility Services (other group clinics): Parent and broader Mehiläinen healthcare group that operates additional fertility and reproductive services across its nationwide private healthcare network—same brand family with overlapping service delivery.
• IVI-RMA Global: One of the world's largest assisted reproduction groups operating clinics across Europe and the Americas—relevant comparable for scale, technology adoption, and clinical outcome benchmarking in IVF.
• TFP Fertility: European fertility clinic group operating across the UK and other markets, offering full IVF, ICSI, PGT, and donor services—relevant comparable for advanced reproductive technology adoption and multi-site operations.

Emerging players

• Genea Biomedx: Australian-origin fertility technology and clinic operator known for Embryoscope and culture media innovation—relevant comparable for the technology infrastructure Felicitas has adopted, and a benchmark for tech-led fertility brands.

Regional players

• Vitanova Fertility Center: Copenhagen-based fertility clinic serving Scandinavian patients—comparable regional peer with overlapping patient flows from Finland and similar Nordic service portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/FelicitasMehilainen
• LinkedInlinkedin.com/company/mehilainen

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Felicitas-Klinikka